AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

Chronic diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases, are major global public health challenges, with their ...

Patients with pancreatic cancer who participate in clinical research have better outcomes. PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision. Clinical trials ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...

Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...

Predicting patient trajectories is a complex task due to several factors, including data non-stationarity, the vast number of ...

A recent study led by Chenyang Lu, the Fullgraf Professor in computer science & engineering in the McKelvey School of Engineering and director of the AI for Health Institute (AIHealth) at Washington ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...